KST
← All Comparisons
Healthcare

Eli Lilly & Co.

LLY
VS

UnitedHealth Group

UNH

Obesity drugs vs health insurance - US healthcare blue chip comparison

Eli Lilly & Co.

LLY
NYSE/NASDAQ
$820.50
15.3 (+1.90%)

Explosive growth with GLP-1 obesity/diabetes drugs Mounjaro/Zepbound. Global top 10 pharma by market cap.

UnitedHealth Group

UNH
NYSE/NASDAQ
$540.30
4.5 (-0.83%)

America's largest health insurance and healthcare company. Revenue diversification through Optum data analytics. Aging population beneficiary.

Key Metrics Comparison

Eli Lilly & Co.
Key Metrics Comparison
UnitedHealth Group
$820.50
Price
$540.30
+1.90%
Change
-0.83%
68.4
P/E Ratio
20.8
$780B
Market Cap
$498B
$950.00
52W High
$630.00
$580.00
52W Low
$440.00
5.2M
Volume
4.1M

About the Companies

Eli Lilly & Co.

Explosive growth with GLP-1 obesity/diabetes drugs Mounjaro/Zepbound. Global top 10 pharma by market cap.

UnitedHealth Group

America's largest health insurance and healthcare company. Revenue diversification through Optum data analytics. Aging population beneficiary.

※ All data is for reference only and not real-time. Investment decisions are the sole responsibility of the investor. This comparison is not investment advice.